AbbVie Receives CHMP Positive Opinion for HUMIRA® (adalimumab) for the Treatment of Pediatric Patients with Chronic Non-infectious Anterior Uveitis

100_0256

“Today’s positive CHMP opinion marks a significant milestone for pediatric uveitis patients … moderately to severely active Crohn’s disease, moderately to severely active ulcerative colitis and non-infectious intermediate, posterior and panuveitis …

Read more